Update on Tumors for the General Neurosurgeon I: Adult Gliomas and Metastases

This course provides the practicing clinician with an up-to-date overview of current management strategies for all types of benign and malignant brain tumors. It includes current research topics,emphasizes practical management issues and examines daily clinical decision-making.

Registration Fee

AANS Members$49
Non-members$79

CME Accreditation

The AANS designates this activity for a maximum of 3.25 AMA PRA Category 1 Credits.

Learning Objectives

After completing this educational activity, participants should be able to:

  • Identify the state-of-the-art management of malignant brain tumors, including glial tumors, meningiomas and skull base tumors.
  • Discuss current concepts in glioma management.
  • Apply current updates about brain tumors to daily clinical practice decision-making.

Faculty

Director(s): 

Mitchel S. Berger, MD, FAANS

Assistant Director: 

Nader Sanai, MD, FAANS

Faculty: 







Reviewer:

Peter Edward Fecci, MD, FAANS 

Steven N. Kalkanis, MD, FAANS

Rohan Ramakrishna, MD, FAANS

Jason P. Sheehan, MD, PhD, FAANS

Andrew E. Sloan, MD, FAANS

Colin Watts, PhD (United Kingdom)

Jeffrey S. Weinberg, MD, FAANS

Alex Michael, MD

 This educational activity was recorded at the 2019 AANS Annual Scientific Meeting.


Disclosure Information

The AANS controls the content and production of this CME activity and attempts to ensure the presentation of balanced, objective information. In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclose any relationship they or their co-authors have with commercial interests, which may be related to the content of their lecture.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere or any other relationship to a commercial interest that provides sufficient reason for disclosure.

It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities. Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, it will be resolved prior to confirmation of the individual’s participation.

All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

NameOrganizationRelationship
Peter Edward Fecci, MD, FAANS Monteris Medical, Esai
Honorarium, Honorarium
Andrew E. Sloan, MD, FAANSMonteris Inc., Surgical Theatre Inc., Merck Pharmaceuticals, Inc., Lentigen Inc.,PharmacoKinesis
Consultant Other Financial Support, Consultant FeesHonorariumStock Shareholder (purchased directi.e. not through Mutual Fundretirement packageetc.), Grants/Research Support,Grants/Research Support


Those who have reported they do not have any relationships with commercial interests:

Mitchel S. Berger, MD, FAANS

Nader Sanai, MD, FAANS

Steven N. Kalkanis, MD, FAANS

Rohan Ramakrishna, MD, FAANS

Jason P. Sheehan, MD, PhD, FAANS

Andrew E. Sloan, MD, FAANS

Colin Watts, PhD (United Kingdom)

Jeffrey S. Weinberg, MD, FAANS

Disclaimer

The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care or course of management does not imply endorsement or disapproval of products.

Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients served.

Accreditation Designation

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this internet enduring material activity for a maximum of 3.25 AMA PRA Category 1 CreditsTM.

Physicians should claim only credit commensurate with the extent of their participation in the activity. 

Term of approval is for three years, beginning from 04/3/2020 until 04/3/2023.

© 2019 American Association of Neurological Surgeons

Key:

Complete
Failed
Available
Locked
Welcome and Introduction
Open to view video.
Open to view video. Mitchel S. Berger, MD, FAANS, FACS
Extent of Resection for Newly-Diagnosed Gliomas
Open to view video.
Open to view video. Nader Sanai, MD, FAANS
Current Treatment for Brain Metastases: The Guidelines and Beyond
Open to view video.
Open to view video. Steven N. Kalkanis, MD, FAANS
Repeat Surgery for Patients with Glioma
Open to view video.
Open to view video. Jeffrey S. Weinberg, MD, FAANS, FACS
Brain Metastasis: Contemporary Management and the Role of SRS
Open to view video.
Open to view video. Jason P. Sheehan, MD, PhD, FAANS
Flourescence-Guided Surgery (FGS) & Laser Interstitial Thermotherapy (LITT)
Open to view video.
Open to view video. Andrew E. Sloan, MD, FAANS
Adult Gliomas and Metastases
Open to view video.
Open to view video. Mitchel S. Berger, MD, FAANS, FACS
An Update on Immunotherapy for Glioblastoma
Open to view video.
Open to view video. Peter Edward Fecci, MD, FAANS
Precision Surgery in the Era of Precision Medicine
Open to view video.
Open to view video. Colin Watts, MBBS FRCS, PhD
CME Evaluation
CME Posttest
10 Questions  |  2 attempts  |  7/10 points to pass
10 Questions  |  2 attempts  |  7/10 points to pass
Evaluation
8 Questions
Certificate
3.25 AMA PRA Category 1 CreditsTM credits  |  Certificate available
3.25 AMA PRA Category 1 CreditsTM credits  |  Certificate available